Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in GSK held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 67.7M | $3.73B | +0.3% | 3.364% | 0.20% |
| 2 | DODGE & COX | 58.7M | $3.24B | -14.4% | 2.917% | 1.78% |
| 3 | Fisher Asset Management, LLC | 34.5M | $1.91B | +4.0% | 1.717% | 0.65% |
| 4 | PRIMECAP MANAGEMENT CO/CA/ | 25.2M | $1.39B | +0.3% | 1.253% | 1.10% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 11.7M | $646.7M | -6.7% | 0.583% | 0.12% |
| 6 | MORGAN STANLEY | 11.0M | $608.8M | +89.3% | 0.548% | 0.04% |
| 7 | GOLDMAN SACHS GROUP INC | 10.3M | $567.9M | +24.9% | 0.512% | 0.07% |
| 8 | ROYAL BANK OF CANADA | 7.5M | $414.3M | -11.5% | 0.373% | 0.07% |
| 9 | STATE STREET CORP | 6.0M | $334.0M | -4.1% | 0.298% | 0.01% |
| 10 | Holocene Advisors, LP | 5.5M | $304.6M | -32.0% | 0.274% | 0.73% |
| 11 | Mondrian Investment Partners LTD | 5.0M | $275.3M | -14.1% | 0.248% | 4.12% |
| 12 | BANK OF MONTREAL /CAN/ | 4.6M | $256.1M | +78.5% | 0.231% | 0.10% |
| 13 | BlackRock, Inc. | 3.6M | $196.0M | +95.7% | 0.177% | 0.00% |
| 14 | Grantham, Mayo, Van Otterloo & Co. LLC | 3.5M | $194.4M | +0.9% | 0.175% | 0.50% |
| 15 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 3.5M | $192.2M | -4.8% | 0.173% | 0.59% |
| 16 | EQUITY INVESTMENT CORP | 3.2M | $177.8M | -21.6% | 0.160% | 3.48% |
| 17 | Connor, Clark & Lunn Investment Management Ltd. | 2.8M | $155.5M | +62.2% | 0.140% | 0.36% |
| 18 | DIMENSIONAL FUND ADVISORS LP | 2.6M | $142.8M | +3.5% | 0.129% | 0.03% |
| 19 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2.4M | $131.2M | -35.2% | 0.118% | 0.11% |
| 20 | SEI INVESTMENTS CO | 2.3M | $126.2M | +40.1% | 0.114% | 0.12% |
| 21 | BANK OF AMERICA CORP /DE/ | 2.2M | $121.8M | -41.2% | 0.110% | 0.01% |
| 22 | UBS Group AG | 2.1M | $117.8M | -66.0% | 0.106% | 0.02% |
| 23 | ENVESTNET ASSET MANAGEMENT INC | 1.8M | $101.4M | -30.5% | 0.091% | 0.03% |
| 24 | Eversept Partners, LP | 1.8M | $98.5M | -33.4% | 0.089% | 6.42% |
| 25 | NORTHERN TRUST CORP | 1.7M | $96.5M | +2.8% | 0.087% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in GSK β a direct measure of their conviction.
Filings activity in GSK during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new GSK position in Q1 2026
Institutions that fully closed their GSK position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,003 | +4.2% | 17.72% | +0.89 pp | $18.90B | +5.3% |
| Q4 2025 | 963 | +12% | 16.83% | +2.19 pp | $17.95B | +15% |
| Q3 2025 | 860 | +0.8% | 14.64% | +2.02 pp | $15.62B | +16% |
| Q2 2025 | 853 | +3.9% | 12.62% | +0.54 pp | $13.46B | +4.4% |
| Q1 2025 | 821 | +1.6% | 12.08% | +2.49 pp | $12.89B | +26% |
| Q4 2024 | 808 | 5.7% | 9.59% | 0.51 pp | $10.23B | 5.1% |
| Q3 2024 | 857 | +1.9% | 10.10% | 1.80 pp | $10.77B | 15% |
| Q2 2024 | 841 | β | 11.90% | β | $12.69B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying GSK stock.
Based on Q1 2026 13F filings, institutional ownership of GSK plc stands at 17.7%, held across 1,003 reporting institutions.
FMR LLC is the largest reported institutional holder of GSK, with approximately 67,661,646 shares worth $3.73B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of GSK, including Fisher Asset Management, LLC.
Our composite Smart Money Score for GSK is 61 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
155 institutions opened new positions in GSK during Q1 2026, while 115 fully exited. 664 added to existing positions and 180 trimmed.
GSK institutional ownership rose by 0.89 percentage points quarter-over-quarter, with a net change of +40 holders.
The top 10 institutions account for 69.5% of all reported 13F value in GSK, and the top 25 account for 82.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
GSK plc (GSK) Institutional Ownership